Sort   by:  
 Page size 
ProteomicsMelanoma spliced and linear HLA-I peptides
In this project we have identifed and linear and spliced HLA-I bound peptides to LM-MEl-44, 53 and 33 cell lines in two different condition, treated and not treated with interferone gamma.
ORGANISM(S): Homo sapiens (Human) 
2020-09-25 | PXD014397 | Pride
Spliced peptides Melanoma Hla peptides 
UnknownSynthesis and sar study of diarylpentanoid analogues as new anti-inflammatory agents.
Not available
S-EPMC6271425 | biostudies-literature
UnknownA necroptosis-independent function of RIPK3 promotes immune dysfunction and prevents control of chronic LCMV infection.
Not available
S-EPMC9931694 | biostudies-literature
ProteomicsA Phosphotriester-Masked Dideoxy-cGAMP Derivative as a Cell-Permeable STING Agonist
2’3’-cyclic GMP-AMP (cGAMP) is a cyclic dinucleotide second messenger in which guanosine and adenosine are connected by one 3’-5’ and one 2’-5’ phosphodiester linkage. It is formed in the cytosol upon detection of pathogenic DNA by the enzyme guanosine-monophosphate-adenosine monophosphate synthase ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-07 | PXD057395 | Pride
Sting Interferone Cgamp 
UnknownThe Identification of Pivotal Transcriptional Factors Mediating Cell Responses to Drugs With Drug-Induced Liver Injury Liabilities.
Not available
S-EPMC6257024 | biostudies-literature
UnknownAffordability of medicines in the European Union.
Not available
S-EPMC5328386 | biostudies-literature
TranscriptomicsA necroptosis-independent function of RIPK3 promotes immune dysfunction and prevents control of chronic LCMV infection
Necroptosis is a lytic and inflammatory form of cell death that is highly constrained to mitigate detrimental collateral tissue damage and impaired immunity. These constraints make it difficult to define the relevance of necroptosis in diseases such as chronic and persistent viral infections and wit...
ORGANISM(S): Mus musculus 
2023-03-12 | GSE224066 | GEO
ProteomicsComparative proteomics for identification of type I interferon response in primary human glioblastoma multiforme cells
Oncolytic virus therapy is a promising direction for cancer treatment. Numerous oncolytic virus strains are under development or examined in clinical trials, there are examples of FDA approved virus vaccines. Although evident progress exists, oncolytic viruses still suffer low efficiency and the mec...
ORGANISM(S): Homo sapiens (Human) 
2022-02-03 | PXD022836 | Pride
Glioblastoma Proteomics Interferone response Lc-ms/ms Oncolytic viruses 
ProteomicsComparative proteomics for identification of type I interferon response in primary human glioblastoma multiforme cells
Oncolytic virus therapy is a promising direction for cancer treatment. Numerous oncolytic virus strains are under development or examined in clinical trials, there are examples of FDA approved virus vaccines. Although evident progress exists, oncolytic viruses still suffer low efficiency and the mec...
ORGANISM(S): Homo sapiens (Human) 
2022-02-03 | PXD022906 | Pride
Glioblastoma Proteomics Interferone response Lc-ms/ms Oncolytic viruses 
GenomicsA necroptosis-independent function of RIPK3 promotes immune dysfunction and prevents control of chronic LCMV infection
A necroptosis-independent function of RIPK3 promotes immune dysfunction and prevents control of chronic LCMV infection
PRJNA929503 | ENA
Sort   by:  
 Page size